The GLP-1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes
Your healthcare provider will consider factors including your previous dose level, duration of interruption, current health status, and treatment goals when determining the appropriate restart strategy
Of course, there is some degree of variability in results with these types of treatments, because how well your body reacts depends upon its max output ability for collagen creation, which declines with age and is always less for certain people (genetic predisposition)
Dosage may be repeated at weekly intervals if necessary
Hypoglycemia risk remains low in people without diabetes
Terawaki Y, Nomiyama T, Kawanami T, Hamaguchi Y, Takahashi H, Tanaka T, Murase K, Nagaishi R, Tanabe M, Yanase T